Advances in active surveillance of metastatic renal cell carcinoma / 中华泌尿外科杂志
Chinese Journal of Urology
;
(12): 548-550, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-994082
ABSTRACT
At present, systemic therapy is the main treatment option for metastatic renal cell carcinoma. However, active surveillance may be an alternative for patients with poor physical status or slow disease progression. Active surveillance can appropriately delay the timing of systematic treatment for some patients with metastatic renal cell carcinoma without affecting their prognosis. We have combined the latest researches to clarify the clinical significance, applicable population, disadvantages, scheme and prognosis of active surveillance in metastatic renal cell carcinoma in recent years in detail.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Urology
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS